13.01.2014 Views

Overview Key Concepts Anesthetic Management Anesthestic ...

Overview Key Concepts Anesthetic Management Anesthestic ...

Overview Key Concepts Anesthetic Management Anesthestic ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Small animal Anesthesia for Imaging<br />

C Garrett 2012<br />

<strong>Anesthestic</strong> Selections<br />

Understand your model and your<br />

mouse!<br />

‣ Strain sensitivity<br />

‣ Genetic modifications (e.g. γ-PKC -/- )<br />

Sonner et al. Anesth Analg 89:1030 – 40 (1999)<br />

<strong>Anesthestic</strong> Selections<br />

Understand your model and your<br />

mouse!<br />

‣ Strain sensitivity<br />

‣ Genetic modifications (e.g. γ-PKC -/- )<br />

‣ Co-morbidities<br />

‣ Organ dysfunction (e.g. DCM, hepatitis, renal<br />

tumors)<br />

‣ Physiologic changes (e.g. hypertension,<br />

bradycardia)<br />

General Anesthesia<br />

1. Loss of consciousness<br />

2. Suppression of muscle activity<br />

3. Analgesia<br />

‣ Single agents (e.g. inhalants)<br />

‣ Combinational therapy (e.g. injectables)<br />

All anesthetic agents have side-effects!<br />

Inhalant Anesthesia<br />

Pros ‣ Rapid induction and<br />

recovery<br />

‣ Titration to effect<br />

‣ Fine control over depth<br />

‣ Minimal residual side-effects<br />

Cons<br />

‣ Newer agents: minimal<br />

organ metabolism<br />

‣ Respiratory depression<br />

‣ Require specific equipment<br />

(e.g. vaporizer, intubation or nose<br />

cone)<br />

Injectable Anesthesia<br />

‣ Does not require specific<br />

equipment<br />

‣ Many types/ combinations<br />

‣ Familiarity<br />

‣ Delayed anesthetic<br />

induction and recovery<br />

‣ Variable side-effects<br />

‣ Renal/hepatic metabolism<br />

‣ Often blind administration<br />

Injectable Anesthesia<br />

‣ Pentobarbital: potentiates GABAnergic neurotransmission<br />

‣ Frequently used agent: hypnosis → anesthesia<br />

‣ Cardiopulmonary depression is dose-dependent<br />

‣ May require ventilatory support with severe respiratory depression<br />

‣ Administration: Mice 50 – 90 mg/kg; Rats 30 – 45 mg/kg (IP)<br />

‣ 2-2-2 Tribromoethanol (Avertin®):<br />

‣ Short-acting 15- 30 minutes of anesthesia<br />

‣ Good muscle relaxation, mild respiratory depression<br />

‣ Purchased as a chemical grade product and requires reconstitution<br />

‣ Light and temperature sensitive: degraded bi-products can cause delayed<br />

nephro/hepatotoxicity and gastrointestinal stasis<br />

‣ Increased fatalities with multiple IP administrations (best for single survival<br />

terminal/acute use)<br />

2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!